chr11-56318964-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001005202.2(OR8K3):āc.658C>Gā(p.Leu220Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000258 in 1,614,142 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001005202.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR8K3 | NM_001005202.2 | c.658C>G | p.Leu220Val | missense_variant | 3/3 | ENST00000641662.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR8K3 | ENST00000641662.1 | c.658C>G | p.Leu220Val | missense_variant | 3/3 | NM_001005202.2 | P1 | ||
OR8K3 | ENST00000641689.1 | c.658C>G | p.Leu220Val | missense_variant | 2/2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152180Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000195 AC: 49AN: 251138Hom.: 0 AF XY: 0.000147 AC XY: 20AN XY: 135728
GnomAD4 exome AF: 0.000265 AC: 387AN: 1461844Hom.: 0 Cov.: 33 AF XY: 0.000230 AC XY: 167AN XY: 727222
GnomAD4 genome AF: 0.000190 AC: 29AN: 152298Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74452
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 27, 2023 | The c.658C>G (p.L220V) alteration is located in exon 1 (coding exon 1) of the OR8K3 gene. This alteration results from a C to G substitution at nucleotide position 658, causing the leucine (L) at amino acid position 220 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at